, World Health Organization, pp.1-262, 2017.

. Ministério-da-saúde, Plano Nacional pelo Fim da Tuberculose como Problema de Saúde Pública, pp.1-57, 2017.

P. Pean, E. Nerrienet, Y. Madec, L. Borand, D. Laureillard et al., Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis, Blood, vol.119, issue.14, pp.3315-3335, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02332685

H. Y. Tan, Y. K. Yong, B. B. Andrade, E. M. Shankar, S. Ponnampalavanar et al., Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome, AIDS, vol.29, p.4, 2015.

V. Vijaya-lakshmi, S. S. Rakh, A. Radha, B. , H. Sai-priya et al., Role of HLA-B51 and HLA-B52 in susceptibility to pulmonary tuberculosis, Infect Genet Evol, vol.6, issue.6, pp.436-445, 2006.

S. Kulkarni, M. P. Martin, and M. Carrington, The Yin and Yang of HLA and KIR in human disease, Semin Immunol, vol.20, pp.343-52, 2008.

G. Kaur and N. Mehra, Genetic determinants of HIV-1 infection and progression to AIDS: immune response genes, Tissue Antigens, vol.74, issue.5, pp.373-85, 2009.

, , 2018.

P. Kiepiela, A. J. Leslie, I. Honeyborne, D. Ramduth, C. Thobakgale et al., Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA, Nature, vol.432, issue.7018, pp.769-75, 2004.

M. Raghavan and J. Geng, HLA-B polymorphisms and intracellular assembly modes, Mol Immunol, vol.68, issue.2, pp.89-93, 2015.

M. Colonna, G. Borsellino, M. Falco, G. B. Ferrara, and J. L. Strominger, HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1-and NK2-specific natural killer cells, Proc Natl Acad Sci, vol.90, issue.24, pp.12000-12004, 1993.

B. Tallon, J. Bruneau, C. M. Tsoukas, J. Routy, Z. Kiani et al., Time to Seroconversion in HIV-Exposed Subjects Carrying Protective versus Non Protective KIR3DS1/L1 and HLA-B Genotypes, e110480 Available from, vol.9, 2014.

J. Fernandes-cardoso, T. A. Süffert, L. Da-g-c, M. Jobim, and P. H. Salim, Association between KIR genotypes and HLA-B alleles on viral load in Southern Brazilian individuals infected by HIV-1 subtypes B and C, Hum Immunol, vol.77, issue.10, pp.854-60, 2016.

M. Paximadis, G. Minevich, R. Winchester, D. B. Schramm, G. E. Gray et al., KIR-HLA and Maternal-Infant HIV-1 Transmission in Sub-Saharan Africa, e16541 Available from, vol.6, 2011.

N. L. Gentle, M. Paximadis, A. Puren, and C. T. Tiemessen, Genetic Variability in Markers of HLA-C Expression in Two Diverse South African Populations

, e67780 Available from, vol.8, 2013.

S. S. Pydi, S. R. Sunder, S. Venkatasubramanian, S. Kovvali, S. Jonnalagada et al., Killer cell immunoglobulin like receptor gene association with tuberculosis, Hum Immunol, vol.74, issue.1, pp.85-92, 2013.

K. Braun, J. Wolfe, S. Kiazyk, and M. K. Sharma, Evaluation of host genetics on outcome of tuberculosis infection due to differences in killer immunoglobulin-like receptor gene frequencies and haplotypes, BMC Genet, vol.16, pp.1-7, 2015.

M. Salie, M. Daya, M. Möller, and E. G. Hoal, Activating KIRs alter susceptibility to pulmonary tuberculosis in a south African population, Tuberculosis, vol.95, issue.6, pp.817-838, 2015.

A. Habegger-de-sorrentino, R. Pardo, K. Marinic, S. C. Duarte, and C. Lotero, KIR-HLA clase i y tuberculosis pulmonar en población amerindia del Chaco, Argentina. Enferm Infecc Microbiol Clin, vol.32, issue.9, pp.565-574, 2014.

R. Yuliwulandari, Q. Sachrowardi, H. Nakajima, K. Kashiwase, K. Hirayasu et al., Association of HLA-A, ?B, and -DRB1 with pulmonary tuberculosis in western Javanese Indonesia, Hum Immunol, vol.71, issue.7, pp.697-701, 2010.

J. F. Figueiredo, L. Rodrigues-mde, N. H. Deghaide, and E. A. Donadi, HLA profile in patients with AIDS and tuberculosis, Braz J Infect Dis, vol.12, issue.4, pp.278-80, 2008.

M. Müller, S. Wandel, R. Colebunders, S. Attia, H. Furrer et al., Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis, Lancet Infect Dis, vol.10, issue.4, pp.251-61, 2010.

R. Lai, G. Meintjes, and R. J. Wilkinson, HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome, Semin Immunopathol, vol.38, issue.2, pp.185-98, 2016.

A. M. Nelson, Y. C. Manabe, and S. B. Lucas, Immune Reconstitution Inflammatory Syndrome (IRIS): What pathologists should know, Semin Diagn Pathol, 2017.

N. F. Walker, J. Scriven, G. Meintjes, and R. J. Wilkinson, Immune reconstitution inflammatory syndrome in HIV-infected patients, HIV AIDS (Auckl), vol.7, pp.49-64, 2015.

D. M. Murdoch, W. D. Venter, A. Van-rie, and C. Feldman, Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options, AIDS Res Ther, vol.4, issue.1, p.9, 2007.

R. Gopal, R. R. Rapaka, and J. K. Kolls, Immune reconstitution inflammatory syndrome associated with pulmonary pathogens, 160042 Available from, vol.26, 2017.

S. D. Lawn and R. Wood, Incidence of Tuberculosis during Highly Active Antiretroviral Therapy in High-Income and Low-Income Countries, Clin Infect Dis, vol.41, issue.12, pp.1783-1789, 2005.

R. Ganji, S. Dhali, A. Rizvi, S. Rapole, and S. Banerjee, Understanding HIV-Mycobacteria synergism through comparative proteomics of intraphagosomal mycobacteria during mono-and HIV co-infection, 22060 Available from, vol.6, 2016.

T. M. Bana, M. Lesosky, D. J. Pepper, H. Van-der-plas, C. Schutz et al., Prolonged tuberculosis-associated immune reconstitution inflammatory syndrome: characteristics and risk factors, BMC Infect Dis, vol.16, issue.1, pp.1-12, 2016.

P. E. Namale, L. H. Abdullahi, S. Fine, M. Kamkuemah, R. J. Wilkinson et al., Paradoxical TB-IRIS in HIV-infected adults: a systematic review and metaanalysis, Future Microbiol, vol.10, issue.6, pp.1077-99, 2015.

F. C. Serra, D. Hadad, R. L. Orofino, F. Marinho, C. Lourenço et al., Immune reconstitution syndrome in patients treated for HIV and tuberculosis in Rio de Janeiro, Braz J Infect Dis, vol.11, issue.5, pp.462-467, 2007.

T. P. Silva, C. Giacoia-gripp, C. A. Schmaltz, F. M. Sant'-anna, V. Rolla et al., T Cell Activation and cytokine profile of Tuberculosis and HIVpositive Individuals during antituberculous treatment and Efavirenz-based regimens, PLoS One, vol.8, issue.6, pp.4-11, 2013.

L. Antonelli, Y. Mahnke, J. N. Hodge, B. O. Porter, D. L. Barber et al., Elevated frequencies of highly activated CD4 T cells in HIV patients developing immune reconstitution inflammatory syndrome, Blood, vol.116, pp.3818-3845, 2010.

H. Tran, R. Van-den-bergh, M. M. Loembé, W. Worodria, H. Mayanja-kizza et al., Modulation of the complement system in monocytes contributes to tuberculosis-associated immune reconstitution inflammatory syndrome, AIDS, vol.27, issue.11, pp.1725-1759, 2013.

H. Tran, R. Van-den-bergh, T. N. Vu, K. Laukens, W. Worodria et al., The role of monocytes in the development of Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome, Immunobiology, 2014.

J. S. Affandi, M. Kumar, U. Agarwal, S. Singh, and P. Price, The search for a genetic factor associating with immune restoration disease in HIV patients coinfected with Mycobacterium tuberculosis, Dis Markers, vol.34, issue.6, pp.445-454, 2013.

C. C. Chang, V. Sheikh, I. Sereti, and M. A. French, Immune reconstitution disorders in patients with HIV infection: from pathogenesis to prevention and treatment, Curr HIV/AIDS Rep, vol.11, issue.3, pp.223-255, 2014.

D. Laureillard, O. Marcy, Y. Madec, S. Chea, S. Chan et al., Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial, AIDS, vol.27, issue.16, pp.2577-86, 2013.

A. F. Luetkemeyer, M. A. Kendall, M. Nyirenda, X. Wu, P. Ive et al., Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs, J Acquir Immune Defic Syndr, vol.65, issue.4, pp.423-431, 2014.

D. B. Meya, Y. C. Manabe, D. R. Boulware, and E. N. Janoff, The immunopathogenesis of cryptococcal immune reconstitution inflammatory syndrome: understanding a conundrum, Curr Opin Infect Dis, vol.29, issue.1, pp.10-22, 2016.

K. Naidoo, N. Yende-zuma, N. Padayatchi, K. Naidoo, N. Jithoo et al., The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial, Ann Intern Med, vol.157, issue.5, pp.313-337, 2012.

O. Goovaerts, W. Jennes, M. Massinga-loembé, P. Ondoa, A. Ceulemans et al., Lower Pre-Treatment T Cell Activation in Early-and Late-Onset Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome, e0133924 Available from, vol.10, 2015.

W. Manosuthi, S. Kiertiburanakul, T. Phoorisri, and S. Sungkanuparph, Immune reconstitution inflammatory syndrome of tuberculosis among HIVinfected patients receiving antituberculous and antiretroviral therapy, J Inf Secur, vol.53, issue.6, pp.357-63, 2006.

R. Lai, G. Meintjes, K. A. Wilkinson, C. M. Graham, S. Marais et al., HIV-tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling, Nat Commun, vol.6, p.8451, 2015.

B. G. Oliver, J. H. Elliott, P. Price, M. Phillips, V. Saphonn et al., Mediators of innate and adaptive Immune responses differentially affect Immune restoration disease Associated with Mycobacterium tuberculosis in HIV Patients beginning antiretroviral therapy, J Infect Dis, vol.202, issue.11, pp.1728-1765, 2010.

T. P. Da-silva, C. Giacoia-gripp, C. A. Schmaltz, F. M. Sant'anna, M. H. Saad et al., Risk factors for increased immune reconstitution in response to Mycobacterium tuberculosis antigens in tuberculosis HIVinfected, antiretroviral-naïve patients, BMC Infect Dis, vol.17, issue.1, pp.1-10, 2017.

C. Giacoia-gripp, . Da-s-c, T. P. Da-silva, F. M. Sant'-anna, and C. De-s-b, Changes in the NK Cell Repertoire Related to Initiation of TB Treatment and Onset of Immune Reconstitution Inflammatory Syndrome in TB/HIV Co-infected Patients in Rio de Janeiro, Brazil-ANRS 12274, Front Immunol, vol.10, p.1800, 2019.
URL : https://hal.archives-ouvertes.fr/pasteur-02292435

M. Da-saúde, Protocolo Clínico e Diretrizes Terapêuticas para Manejo da Infecção pelo HIV em Adultos | Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis, 2018.

M. Saúde and . Da, Manual De Recomendações Para O Controle Da Tuberculose No Brasil, 2011.

J. Robertson, M. Meier, J. Wall, J. Ying, and C. J. Fichtenbaum, Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy, Clin Infect Dis, vol.42, issue.11, pp.1639-1685, 2006.

G. Meintjes and L. Lynen, Prevention and treatment of the immune reconstitution inflammatory syndrome, Curr Opin HIV AIDS, vol.3, issue.4, pp.468-76, 2008.

F. O. Demitto, C. Schmaltz, F. M. Sant'anna, M. B. Arriaga, B. B. Andrade et al., Predictors of early mortality and effectiveness of antiretroviral therapy in TB-HIV patients from Brazil. Nicastri E, editor, e0217014 Available from, vol.14, 2019.

J. Robinson, J. A. Halliwell, H. Mcwilliam, R. Lopez, and S. Marsh, IPD-the Immuno Polymorphism Database, 2013.

O. Mandelboim, H. T. Reyburn, M. Valés-gómez, L. Pazmany, M. Colonna et al., Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules, J Exp Med, vol.184, issue.3, pp.913-935, 1996.

R. M. Faridi and S. Agrawal, Killer immunoglobulin-like receptors (KIRs) and HLA-C allorecognition patterns implicative of dominant activation of natural killer cells contribute to recurrent miscarriages, Hum Reprod, vol.26, issue.2, pp.491-498, 2011.

M. Uhrberg, N. M. Valiante, B. P. Shum, H. G. Shilling, K. Lienert-weidenbach et al., Human Diversity in Killer Cell Inhibitory Receptor Genes. Immunity, vol.7, issue.6, pp.753-63, 1997.

A. Agresti, An Introduction to Categorical Data Analysis, 2002.

M. P. Fay and E. J. Feuer, Confidence Intervals For Directly Standardized Rates: A Method Based On The Gamma Distribution, Stat Med, vol.16, p.791, 1997.

. Instituto-brasileiro-de-geografia-e-estatística, Características étnico -raciais da população: classificação e identidades. Estudos e Análises: informação demográfica e socioeconômica, pp.83-99, 2013.

X. Gao, T. R. O'brien, T. M. Welzel, D. Marti, Y. Qi et al., HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection, AIDS, vol.24, issue.12, pp.1835-1875, 2010.

P. Takejima, R. C. Agondi, H. Rodrigues, M. V. Aun, J. Kalil et al., Allergic and Nonallergic Asthma Have Distinct Phenotypic and Genotypic Features, Int Arch Allergy Immunol, vol.172, issue.3, pp.150-60, 2017.

M. P. Martin and M. Carrington, Immunogenetics of HIV disease, Immunol Rev, vol.254, issue.1, pp.245-64, 2013.

C. M. Stein, L. Sausville, C. Wejse, R. S. Sobota, N. M. Zetola et al., Genomics of human pulmonary tuberculosis: from genes to pathways, Curr Genet Med Rep, vol.5, issue.4, pp.149-66, 2017.

K. A. Wilkinson and N. Walker, Biomarkers for identifying risk of Immune Reconstitution Inflammatory Syndrome, EBioMed, vol.4, pp.9-10, 2016.

V. George, L. Harrison, M. Roach, X. Li, C. Tierney et al., Associations of plasma cytokine and microbial translocation biomarkers with Immune Reconstitution Inflammatory Syndrome, J Infect Dis, vol.216, issue.9, pp.1159-63, 2017.

A. Conesa-botella, G. Meintjes, A. K. Coussens, H. Van-der-plas, R. Goliath et al., Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome, Clin Infect Dis, vol.55, issue.7, pp.1004-1015, 2012.

A. Bourgarit, G. Carcelain, A. Samri, C. Parizot, M. Lafaurie et al., Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells, J Immunol, vol.183, issue.6, pp.3915-3938, 2009.

. Conradie, Natural Killer cell activation distinguishes M. tuberculosismediated Immune reconstitution syndrome (IRIS) from chronic HIV and HIV-MTB co-infection, J Acquir Immune Defic Syndr, vol.58, issue.3, pp.309-327, 2011.

S. Teixeira, N. De-sá, D. P. Campos, A. B. Coelho, M. L. Guimarães et al., Association of the HLA-B*52 allele with non-progression to AIDS in Brazilian HIV-1-infected individuals, Genes Immun, vol.15, issue.4, pp.256-62, 2014.

M. Halagan, D. C. Oliveira, M. Maiers, R. A. Fabreti-oliveira, M. Moraes et al., The distribution of HLA haplotypes in the ethnic groups that make up the Brazilian Bone Marrow Volunteer Donor Registry (REDOME), Immunogenetics, vol.70, issue.8, pp.511-533, 2018.

C. M. Ayo, C. Da-silveira, D. H. Xavier, M. F. Batista, O. A. Carneiro et al., Frequencies of allele groups HLA-A, HLA-B and HLA-DRB1 in a population from the northwestern region of São Paulo state, Brazil, Int J Immunogenet, vol.42, issue.1, pp.19-25, 2015.

L. Torres, L. F. Da-silva-bouzas, A. Almada, L. De-sobrino-porto, and E. Abdelhay, Distribution of HLA-A, ?B and -DRB1 antigenic groups and haplotypes from the Brazilian bone marrow donor registry (REDOME), Hum Immunol, vol.78, issue.10, pp.602-611, 2017.

C. Rudnick, D. Franceschi, A. V. Marangon, G. Guelsin, A. M. Sell et al., Killer cell immunoglobulin-like receptor gene diversity in a southern Brazilian population from the state of Paraná, Hum Immunol, vol.69, issue.12, pp.872-878, 2008.

M. Jobim, P. H. Salim, P. Portela, T. J. Wilson, J. Fraportti et al., Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil, Int J Immunogenet, vol.37, issue.2, pp.83-92, 2010.

D. G. Augusto, L. Zehnder-alves, M. R. Pincerati, M. P. Martin, M. Carrington et al., Diversity of the KIR gene cluster in an urban Brazilian population, Immunogenetics, vol.64, issue.2, pp.143-52, 2012.

A. J. Mcneil, P. L. Yap, S. M. Gore, R. P. Brettle, M. Mccoll et al., Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease, QJM, vol.89, issue.3, pp.177-85, 1996.

M. Carrington and S. J. O'brien, The Influence of HLA Genotype on AIDS, Annu Rev Med, vol.54, issue.1, pp.535-51, 2003.

H. Y. Tan, Y. K. Yong, E. M. Shankar, G. Paukovics, R. Ellegård et al., Aberrant Inflammasome Activation Characterizes Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome, J Immunol, vol.196, issue.10, pp.4052-63, 2016.

U. Shankarkumar, A. Pawar, G. Prabu, and K. Ghosh, Role of HLA class i (HLA-A, B) and HLA class II (HLA-DRB, DQB) in HIV-1 patients with and without pulmonary tuberculosis, J Acquir Immune Defic Syndr, vol.51, pp.640-641, 2009.

E. E. Mcclelland and J. M. Smith, Gender Specific Differences in the Immune Response to Infection, Arch Immunol Ther Exp, vol.59, issue.3, pp.203-216, 2011.

S. L. Klein, Hormonal and immunological mechanisms mediating sex differences in parasite infection, Parasite Immunol, vol.26, issue.6-7, pp.247-64, 2004.

, , 2019.

C. Herzmann, G. Sotgiu, O. Bellinger, R. Diel, S. Gerdes et al., Risk for latent and active tuberculosis in Germany, Infection, vol.45, issue.3, pp.283-90, 2017.

H. J. Pegram, D. M. Andrews, M. J. Smyth, P. K. Darcy, and M. H. Kershaw, Activating and inhibitory receptors of natural killer cells, Immunol Cell Biol, vol.89, issue.2, pp.216-240, 2011.

G. Alter, D. Heckerman, A. Schneidewind, L. Fadda, C. M. Kadie et al., HIV-1 adaptation to NK-cell-mediated immune pressure, Nature, vol.476, issue.7358, pp.96-100, 2011.

S. L. Gooneratne, J. Richard, W. S. Lee, A. Finzi, S. J. Kent et al., Slaying the Trojan horse: natural killer cells exhibit robust anti-HIV-1 antibodydependent activation and cytolysis against allogeneic T cells, J Virol, vol.89, issue.1, pp.97-109, 2015.

M. K. Misra, S. Prakash, N. R. Moulik, A. Kumar, and S. Agrawal, Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians, Hum Immunol, vol.77, issue.1, pp.41-47, 2016.

W. Barcelos, R. Sathler-avelar, O. A. Martins-filho, B. N. Carvalho, T. Guimarães et al., Natural Killer Cell Subpopulations in Putative Resistant Individuals and Patients with Active Mycobacterium tuberculosis Infection, Scand J Immunol, vol.68, issue.1, pp.92-102, 2008.

F. Bozzano, P. Costa, G. Passalacqua, F. Dodi, S. Ravera et al., Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment, Int Immunol, vol.21, issue.7, pp.779-91, 2009.

D. Portevin, L. E. Via, S. Eum, and D. Young, Natural killer cells are recruited during pulmonary tuberculosis and their ex vivo responses to mycobacteria vary between healthy human donors in association with KIR haplotype, Cell Microbiol, vol.14, issue.11, pp.1734-1778, 2012.

A. Méndez, H. Granda, A. Meenagh, S. Contreras, R. Zavaleta et al., Study of KIR genes in tuberculosis patients, Tissue Antigens, vol.68, issue.5, pp.386-395, 2006.

R. Mahfouz, H. Halas, R. Hoteit, M. Saadeh, W. Shamseddeen et al., Study of KIR genes in Lebanese patients with tuberculosis, Int J Tuberc Lung Dis, vol.15, issue.12, pp.1688-91, 2011.

T. G. Biberg-salum, A. Vr, P. Nhs-d,-de, and E. C. Castelli, HLA-C Alleles and Cytomegalovirus Retinitis in Brazilian Patients with AIDS, J Ophthalmol, vol.2018, pp.1-5, 2018.

S. A. Shelburne, F. Visnegarwala, J. Darcourt, E. A. Graviss, T. P. Giordano et al., Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy, vol.19, p.399, 2005.

R. M. Srivastava and A. Khar, Activating and inhibitory receptors and their role in Natural Killer cell function, Indian J Biochem Biophys, vol.40, 2003.

E. O. Long, Negative signalling by inhibitory receptors: the NK cell paradigm, 2018.

P. H. Salim, M. Jobim, L. F. Jobim, and R. M. Xavier, Doenças reumatológicas autoimunes e sua associação com os genes killer immunoglobulin-like receptors, Rev Bras Reumatol, vol.51, issue.4, pp.357-64, 2011.

, Publisher's Note

, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations